NNC0123-0000-0338

· Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for NNC0123-0000-0338, covering 2014-01-06 to 2019-03-18. Get the full timeline:

Most recent: Clinical Trial Update: Trial to Compare NNC0123-0000-0338 in a Tablet Formulation and Insulin Glargine in Subjects With Type 2 Diabetes Currently Treated With Oral Antidiabetic Therapy [Phase 2]

See pricing